Consistently, treatment with a well-established METTL3 inhibitor, STM2457 [42], also remarkably restrained the methionine-induced RNA m6A signal in ESCC cells (Fig. 3I). The gene discussed is METTL3; the disease is esophageal squamous cell carcinoma.